TrademarkOpen
Search / United States / 98200315

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

MICIT

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and/or proteins…
Show more

Class 5: Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and/or proteins; Medicines individually tailored for the respective patient, in particular based on nucleic acids and proteins, namely, pharmaceutical preparations for treatment of cancer
Class 9: Scientific apparatus and instruments, namely, downloadable mobile software applications for personalized cancer patient information; Software algorithms, namely, downloadable software programs for detecting and registering mutations in cancer patients
Class 10: Medical devices, namely, high-throughput analysis devices for next-generation sequencing for gene expression profiling and for the detection of epigenetic changes
Class 42: Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and therapy using molecular biological, genetic engineering, biotechnological and/or bioinformatic methods, in particular using next-generation sequencing; Scientific laboratory services and scientific research for medical purposes in the field of oncology, namely, diagnostics of tumor markers for personalized therapy
Class 44: Medical, veterinary and pharmaceutical consultancy, in particular with regard to the selection of suitable therapies for all types of cancer; Medical services, namely, conducting analyzes and treatments in the field of personalized cancer immunotherapy; Medical services, namely, providing nucleic acid based therapies and checkpoint inhibitors

Class 5 – Pharmaceuticals & supplementsClass 9 – Software, electronics & scientificClass 10 – Medical apparatusClass 42 – Technology & SaaSClass 44 – Medical & beauty services

Status timeline

  1. 30 Sep 2023
    Application filed
    New Application Entered
  2. 20 May 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 28 May 2024
    Approved for publication
    Approved For Pub - Principal Register
  4. 2 Jul 2024
    Published for opposition
    Published For Opposition
  5. 27 Aug 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 9 Dec 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 12 Aug 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  8. 14 Jan 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 28 events
2026-08-25Notice Of Approval Of Extension Request E-Mailed
2026-08-24Sou Teas Extension Received
2026-08-24Sou Extension 4 Filed
2026-08-24Sou Extension 4 Granted
2026-01-15Notice Of Approval Of Extension Request E-Mailed
2026-01-14Sou Teas Extension Received
2026-01-14Sou Extension 3 Filed
2026-01-14Sou Extension 3 Granted
2025-08-13Notice Of Approval Of Extension Request E-Mailed
2025-08-12Sou Teas Extension Received
2025-08-12Sou Extension 2 Filed
2025-08-12Sou Extension 2 Granted
2025-03-03Notice Of Approval Of Extension Request E-Mailed
2024-12-09Sou Teas Extension Received
2024-12-09Sou Extension 1 Filed
2024-12-09Sou Extension 1 Granted
2024-08-27Noa Mailed - Sou Required From Applicant
2024-07-02Published For Opposition
2024-07-02Official Gazette Publication Confirmation E-Mailed
2024-06-12Notification Of Notice Of Publication E-Mailed
2024-05-28Examiners Amendment -Written
2024-05-28Examiners Amendment E-Mailed
2024-05-28Notification Of Examiners Amendment E-Mailed
2024-05-28Examiner's Amendment Entered
2024-05-28Approved For Pub - Principal Register
2024-05-20Assigned To Examiner
2023-10-11New Application Office Supplied Data Entered
2023-09-30New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and/or proteins; Medicines individually tailored for the respective patient, in particular based on nucleic acids and proteins, namely, pharmaceutical preparations for treatment of cancer

Class 9 Software, electronics & scientific

Scientific apparatus and instruments, namely, downloadable mobile software applications for personalized cancer patient information; Software algorithms, namely, downloadable software programs for detecting and registering mutations in cancer patients

Class 10 Medical apparatus

Medical devices, namely, high-throughput analysis devices for next-generation sequencing for gene expression profiling and for the detection of epigenetic changes

Class 42 Technology & SaaS

Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and therapy using molecular biological, genetic engineering, biotechnological and/or bioinformatic methods, in particular using next-generation sequencing; Scientific laboratory services and scientific research for medical purposes in the field of oncology, namely, diagnostics of tumor markers for personalized therapy

Class 44 Medical & beauty services

Medical, veterinary and pharmaceutical consultancy, in particular with regard to the selection of suitable therapies for all types of cancer; Medical services, namely, conducting analyzes and treatments in the field of personalized cancer immunotherapy; Medical services, namely, providing nucleic acid based therapies and checkpoint inhibitors

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 25 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.